IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
(NASDAQ: ICCM) Delayed: 1.96 -0.03 (1.51%)
Previous Close $1.99    52 Week High $ 
Open $2.06    52 Week Low $ 
Day High $2.06    P/E N/A 
Day Low $1.95    EPS $ 
Volume 80,260